Prolonged half‐life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interaction
暂无分享,去创建一个
W. Wilson | B. Moriyama | T. Walsh | Xuan Huang | J. Leung | O. Falade-Nwulia | S. Penzak | Stacey A. Henning | Caroline Jjingo